BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28128540)

  • 1. Determinants of aortic regurgitation after transcatheter aortic valve implantation. An observational study using multi-slice computed tomography-guided sizing.
    Rahhab Z; El Faquir N; Rodríguez-Olivares R; Ren C; van Mieghem N; Geleijnse ML; Schultz C; van Domburg R; de Jaegere PP
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):598-605. PubMed ID: 28128540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT predictors of post-procedural aortic regurgitation in patients referred for transcatheter aortic valve implantation: an analysis of 105 patients.
    Marwan M; Achenbach S; Ensminger SM; Pflederer T; Ropers D; Ludwig J; Weyand M; Daniel WG; Arnold M
    Int J Cardiovasc Imaging; 2013 Jun; 29(5):1191-8. PubMed ID: 23420354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
    Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
    JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation.
    Takagi K; Latib A; Al-Lamee R; Mussardo M; Montorfano M; Maisano F; Godino C; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):432-43. PubMed ID: 21793168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prosthesis-patient mismatch after transcatheter aortic valve implantation: impact of 2D-transthoracic echocardiography versus 3D-transesophageal echocardiography.
    da Silva C; Sahlen A; Winter R; Bäck M; Rück A; Settergren M; Manouras A; Shahgaldi K
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1549-57. PubMed ID: 25102782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal prosthesis sizing in transcatheter aortic valve implantation by exclusive use of three-dimensional transoesophageal echocardiography.
    Kretzschmar D; Lauten A; Goebel B; Doenst T; Poerner TC; Ferrari M; Figulla HR; Hamadanchi A
    Clin Physiol Funct Imaging; 2016 Mar; 36(2):99-105. PubMed ID: 25316588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of paravalvular leakage after transcatheter aortic valve implantation.
    Di Martino LF; Vletter WB; Ren B; Schultz C; Van Mieghem NM; Soliman OI; Di Biase M; de Jaegere PP; Geleijnse ML
    Int J Cardiovasc Imaging; 2015 Oct; 31(7):1461-8. PubMed ID: 26187523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
    D'Ancona G; Agma HU; Ince H; El-Achkar G; Dißmann M; Ortak J; Kische S
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):135-142. PubMed ID: 27739165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
    Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
    JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
    Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence.
    Détaint D; Lepage L; Himbert D; Brochet E; Messika-Zeitoun D; Iung B; Vahanian A
    JACC Cardiovasc Interv; 2009 Sep; 2(9):821-7. PubMed ID: 19778769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
    Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis.
    Schultz CJ; Tzikas A; Moelker A; Rossi A; Nuis RJ; Geleijnse MM; van Mieghem N; Krestin GP; de Feyter P; Serruys PW; de Jaegere PP
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):446-55. PubMed ID: 21793166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
    García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
    Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valvular performance and aortic regurgitation following transcatheter aortic valve replacement using Edwards valve versus CoreValve for severe aortic stenosis: A Meta-analysis.
    Bhatheja S; Panchal HB; Barry N; Mukherjee D; Uretsky BF; Paul T
    Cardiovasc Revasc Med; 2016 Jun; 17(4):248-55. PubMed ID: 26948087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis.
    Schultz C; Rossi A; van Mieghem N; van der Boon R; Papadopoulou SL; van Domburg R; Moelker A; Mollet N; Krestin G; van Geuns RJ; Nieman K; de Feyter P; Serruys PW; de Jaegere P
    EuroIntervention; 2011 Sep; 7(5):564-72. PubMed ID: 21930460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D Assessment of Features Associated With Transvalvular Aortic Regurgitation After TAVR: A Real-Time 3D TEE Study.
    Shibayama K; Mihara H; Jilaihawi H; Berdejo J; Harada K; Itabashi Y; Siegel R; Makkar RR; Shiota T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):114-23. PubMed ID: 26777225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement.
    Masri A; Schoenhagen P; Svensson L; Kapadia SR; Griffin BP; Tuzcu EM; Desai MY
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1847-54. PubMed ID: 23870156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.